| __timestamp | Bio-Techne Corporation | Rhythm Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 30945000 | 5280000 |
| Thursday, January 1, 2015 | 40853000 | 7148000 |
| Friday, January 1, 2016 | 45187000 | 19594000 |
| Sunday, January 1, 2017 | 53514000 | 22894000 |
| Monday, January 1, 2018 | 55329000 | 50337000 |
| Tuesday, January 1, 2019 | 62413000 | 109450000 |
| Wednesday, January 1, 2020 | 65192000 | 90450000 |
| Friday, January 1, 2021 | 70603000 | 104128000 |
| Saturday, January 1, 2022 | 87140000 | 108630000 |
| Sunday, January 1, 2023 | 92493000 | 134951000 |
| Monday, January 1, 2024 | 96664000 |
In pursuit of knowledge
In the ever-evolving biotech industry, research and development (R&D) investments are crucial for innovation and growth. Over the past decade, Bio-Techne Corporation and Rhythm Pharmaceuticals, Inc. have demonstrated contrasting trajectories in their R&D spending. From 2014 to 2023, Bio-Techne's R&D expenses grew by approximately 212%, reflecting a steady commitment to innovation. In contrast, Rhythm Pharmaceuticals saw a staggering increase of over 2,400% in the same period, highlighting its aggressive push towards groundbreaking solutions.
By 2023, Rhythm Pharmaceuticals' R&D investment reached its peak, surpassing Bio-Techne by nearly 46%. This surge underscores Rhythm's strategic focus on expanding its research capabilities. However, data for 2024 is incomplete, leaving room for speculation on future trends. As these companies continue to invest in R&D, their contributions to the biotech landscape will undoubtedly shape the industry's future.
Who Prioritizes Innovation? R&D Spending Compared for Eli Lilly and Company and Rhythm Pharmaceuticals, Inc.
R&D Spending Showdown: AbbVie Inc. vs Bio-Techne Corporation
Who Prioritizes Innovation? R&D Spending Compared for Sanofi and Rhythm Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Regeneron Pharmaceuticals, Inc. and Rhythm Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: United Therapeutics Corporation vs Bio-Techne Corporation
United Therapeutics Corporation vs Rhythm Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Ionis Pharmaceuticals, Inc. and Rhythm Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: CymaBay Therapeutics, Inc. vs Rhythm Pharmaceuticals, Inc.
R&D Spending Showdown: Rhythm Pharmaceuticals, Inc. vs Veracyte, Inc.
Comparing Innovation Spending: Rhythm Pharmaceuticals, Inc. and Iovance Biotherapeutics, Inc.
Research and Development Expenses Breakdown: Rhythm Pharmaceuticals, Inc. vs MannKind Corporation
Who Prioritizes Innovation? R&D Spending Compared for Rhythm Pharmaceuticals, Inc. and Galapagos NV